• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCU
Click for more information
0.00% 4.3¢

REAL ESTATE CAPITAL PARTNERS USA PROPERTY TRUST

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RCU
Ann: Change of name and ASX code-RCU.AX 		24/10/16 0 659
24/10/16 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  659 
RCU
Ann: Appendix 4G-RCU.AX 		30/09/16 0 163
30/09/16 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  163 
RCU
Ann: Annual Report 2016-RCU.AX 		30/09/16 0 208
30/09/16 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  208 
RCU
Ann: Appendix 3X-RCU.AX 		21/09/16 0 175
21/09/16 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  175 
RCU
Ann: Director Appointment/Resignation-RCU.AX 		21/09/16 0 176
21/09/16 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  176 
RCU
Ann: Becoming a substantial holder-RCU.AX 		08/09/16 0 138
08/09/16 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  138 
RCU
Ann: Change in substantial holding-RCU.AX 		06/09/16 0 120
06/09/16 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  120 
RCU
Ann: Appendix 4E and Financial Report 2016-RCU.AX 		31/08/16 0 148
31/08/16 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  148 

See All Discussions arrow Created with Sketch.

Top Stories

The winners & losers on market if negative gearing were gone

Removing negative gearing would likely cause a seismic shift in investor behaviour. If that advantage were taken away, more investors might start eyeing the stock market...
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core Strickland Metals Ltd has found an extensive zone of high-grade gold and base metals mineralisation at its Rogozna project
ACCC seeks Olam divestments before it can buy Namoi Cotton Australia's market regulator the ACCC has expressed further concerns about the potential takeover of Namoi Cotton by Olam Agri.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.